Table of Contents

company-logo

Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.

Summit Therapeutics Dividend Announcement

• Summit Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Summit Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Summit Therapeutics Dividend History

Summit Therapeutics Dividend Yield

Summit Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Summit Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Summit Therapeutics Financial Ratios

P/E ratio-70.90
PEG ratio-1.61
P/B ratio31.84
ROE-104.22%
Payout ratio0.00%
Current ratio8.31
Quick ratio8.30
Cash Ratio1.59

Summit Therapeutics Dividend FAQ

Does Summit Therapeutics stock pay dividends?
Summit Therapeutics does not currently pay dividends to its shareholders.
Has Summit Therapeutics ever paid a dividend?
No, Summit Therapeutics has no a history of paying dividends to its shareholders. Summit Therapeutics is not known for its dividend payments.
Why doesn't Summit Therapeutics pay dividends?
There are several potential reasons why Summit Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Summit Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Summit Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Summit Therapeutics a dividend aristocrat?
Summit Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Summit Therapeutics a dividend king?
Summit Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Summit Therapeutics a dividend stock?
No, Summit Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Summit Therapeutics stocks?
To buy Summit Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Summit Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.